ArticlePloS one2016

Risk Factors for Poor Adherence to Betaferon® Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome.

Łukasz Jernas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.